Treatment outcome and prognostic factors in PCNSL-Reference-Cited by-同舟云学术

Treatment outcome and prognostic factors in PCNSL

Published:2019-06-13 Issue:1 Volume:14 Page:
ISSN:1746-1596
Container-title:Diagnostic Pathology
language:en
Short-container-title:Diagn Pathol

Author:

Niparuck Pimjai,Boonsakan Paisarn,Sutthippingkiat Taksayut,Pukiat Sulada,Chantrathammachart Pichika,Phusanti Sithakom,Boonyawat Kochawan,Puavilai Teeraya,Angchaisuksiri Pantep,Ungkanont Artit,Chuncharunee Suporn,Atichartakarn Vichai

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13000-019-0833-1.pdf

Reference24 articles.

1. Berglund M, Thunberg U, Amini RM, Book M, Roos G, Erlanson M, et al. Evaluation of immune-phenotype in diffuse large B-cell lymphoma and its impact on prognosis. Mod Pathol. 2005;18:1113–20.

2. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–11.

3. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937–47.

4. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immuno-histochemistry using a tissue microarray. Blood. 2004;103:275–82.

5. Rubenstein JL, Gupta NK, Mannis GN, Lamarre AK, Treseler P, et al. How I treat CNS lymphomas. Blood. 2013;122:2318–30.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of Disease Progression in patients with newly diagnosed Primary Central Nervous System Lymphoma Following Treatment with High-Dose Methotrexate;2024-04-18

2. Brain tumor grading diagnosis using transfer learning based on optical coherence tomography;Biomedical Optics Express;2024-03-13

3. Survival outcomes and treatment experience of 124 patients with primary central nervous system lymphoma;Strahlentherapie und Onkologie;2024-03-11

4. Extranodal lymphoma: pathogenesis, diagnosis and treatment;Molecular Biomedicine;2023-09-18

5. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study;Annals of Hematology;2023-06-08